4//SEC Filing
Bohnen Shane 4
Accession 0001062993-25-007136
CIK 0000842023other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:25 PM ET
Size
24.1 KB
Accession
0001062993-25-007136
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Bohnen Shane
SVP - General Counsel
Transactions
- Exercise/Conversion
Common Stock
2025-04-03+2,260→ 3,941 total - Exercise/Conversion
Restricted Stock Units
2025-04-03−2,260→ 2,259 total→ Common Stock (2,260 underlying) - Tax Payment
Common Stock
2025-04-03$54.86/sh−747$40,980→ 3,194 total
Holdings
- 8,944
Stock Option (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (8,944 underlying) - 3,460
Stock Option (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (3,460 underlying) - 99
Restricted Stock Units
→ Common Stock (99 underlying) - 12,924
Performance Stock Option (Right to Buy)
Exercise: $84.61→ Common Stock (12,924 underlying) - 10,012
Performance Restricted Stock Units
→ Common Stock (10,012 underlying) - 5,006
Restricted Stock Units
→ Common Stock (5,006 underlying) - 16,302
Stock Option (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (16,302 underlying) - 3,508
Stock Option (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (3,508 underlying) - 4,802
Performance Restricted Stock Units
→ Common Stock (4,802 underlying) - 8,848
Stock Option (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (8,848 underlying) - 3,928
Stock Option (Right to Buy)
Exercise: $73.76Exp: 2030-04-03→ Common Stock (3,928 underlying) - 13,488
Stock Option (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (13,488 underlying)
Footnotes (12)
- [F1]Fully exercisable.
- [F10]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F11]1,668 restricted stock units vest on 8/15/2025, and 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
- [F12]Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- [F2]Options to purchase 864 shares vest on each of 8/6/2022, 8/6/2024 and 8/6/2025, and options to purchase 868 shares vest on 8/6/2023.
- [F3]Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
- [F4]Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
- [F5]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F6]2,259 restricted stock units vest on 4/3/2026.
- [F7]Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
- [F8]50 restricted stock units vest on 8/15/2025, and 49 restricted stock units vest on 8/15/2026.
- [F9]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001969581
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:25 PM ET
- Size
- 24.1 KB